NEUROCRINE BIOSCIENCES INC (NBIX) › Cost of RevenueNEUROCRINE BIOSCIENCES INC (NBIX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $02017: $1.25M2018: $4.89M2020: $10.10M2021: $14.30M2022: $23.20M2023: $39.70M2024: $34.00M2025: $52.10M$52.10M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$52.10M+53.2%2024$34.00M-14.4%2023$39.70M+71.1%2022$23.20M+62.2%2021$14.30M+41.6%2020$10.10M—2018$4.89M+289.9%2017$1.25M—2016$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share